SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-24-159983
Filing Date
2024-06-12
Accepted
2024-06-12 16:32:11
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d792363df3.htm F-3 376209
2 EX-5.1 d792363dex51.htm EX-5.1 25438
3 EX-23.1 d792363dex231.htm EX-23.1 2117
4 EX-FILING FEES d792363dexfilingfees.htm EX-FILING FEES 13590
5 GRAPHIC g792363dsp55.jpg GRAPHIC 1849
6 GRAPHIC g792363g0612092419119.jpg GRAPHIC 7243
7 GRAPHIC g792363g0612101052769.jpg GRAPHIC 4382
  Complete submission text file 0001193125-24-159983.txt   437434
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-280145 | Film No.: 241038829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)